Endovascular Therapy of Acute Ischemic Stroke in Patients with Large-Vessel Occlusion Associated with Active Malignancy.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 17 10 2020
revised: 29 10 2020
accepted: 30 10 2020
pubmed: 27 11 2020
medline: 26 1 2021
entrez: 26 11 2020
Statut: ppublish

Résumé

There is limited data on the effectiveness of endovascular therapy (EVT) in stroke patients with active malignancy. In this study, we investigated the outcome of EVT for acute ischemic stroke for patients with active malignancy compared to those without malignancy. We selected patients who underwent EVT for acute ischemic stroke between January 2015 and July 2019. Patients were divided into two groups, those with active malignancy (oncology group - OG) and those without (non-oncology group, NOG). 300 patients were included in this study. There were 19 EVT procedures (18 patients) in the OG and 285 procedures (282 patients) in the NOG. There was no difference in recanalization success rate (mTICI 2b & 3) between the groups: 94.7% versus 80.9% in OG and NOG respectively (p = 0.13). Success rate using the direct aspiration (ADAPT) technique of EVT was not different between compared groups (42.9% versus 67.7%; p = 0.18). However, when using smaller-caliber aspiration devices, ADAPT was less successful in OG (0.0% versus 64.7%, p < 0.05). There was no difference in recanalization success rate of EVT when using a stent-retriever or combined technique. Patients in the OG had a less favorable functional outcome than in the NOG group (mRS 0-2 at 90-days post event: 22.2% versus 48.2%, p < 0.05) CONCLUSION: The technical success rate of EVT in patients with active malignancy is similar to the general population of stroke patients. Interestingly, the success rate of EVT using the ADAPT technique was lower in the OG when using smaller caliber aspiration devices.

Identifiants

pubmed: 33242784
pii: S1052-3057(20)30873-9
doi: 10.1016/j.jstrokecerebrovasdis.2020.105455
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0
Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105455

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Tomohiko Ozaki (T)

Division of Neuroradiology, JDMI, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: tomohikoozaki@gmail.com.

Patrick Nicholson (P)

Division of Neuroradiology, JDMI, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Patrick.Nicholson@uhn.ca.

Joanna D Schaafsma (JD)

Department of Medicine (Neurology), Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Joanna.Schaafsma@uhn.ca.

Ronit Agid (R)

Division of Neuroradiology, JDMI, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Ronit.Agid@uhn.ca.

Timo Krings (T)

Division of Neuroradiology, JDMI, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada; Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Timo.Krings@uhn.ca.

Aleksandra Pikula (A)

Department of Medicine (Neurology), Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Aleksandra.Pikula@uhn.ca.

Vitor Mendes Pereira (VM)

Division of Neuroradiology, JDMI, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada; Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst St, Toronto, Ontario, M5T2S8, Canada. Electronic address: Vitor.Pereira@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH